451 related articles for article (PubMed ID: 19340686)
21. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
Dayal S; Sahu P; Dua R
J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
[TBL] [Abstract][Full Text] [Related]
23. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
[TBL] [Abstract][Full Text] [Related]
24. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
25. Combined Jessner Solution and Trichloroacetic Acid Versus Trichloroacetic Acid Alone in the Treatment of Melasma in Dark-Skinned Patients.
Abdel-Meguid AM; Taha EA; Ismail SA
Dermatol Surg; 2017 May; 43(5):651-656. PubMed ID: 28178004
[TBL] [Abstract][Full Text] [Related]
26. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
27. A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
Kwon HH; Ohn J; Suh DH; Park HY; Choi SC; Jung JY; Kwon IH; Park GH
J Dermatolog Treat; 2017 Mar; 28(2):155-159. PubMed ID: 27346606
[TBL] [Abstract][Full Text] [Related]
28. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment.
Ertam Sagduyu I; Marakli O; Oraloglu G; Bulut Okut E; Unal I
Dermatol Ther; 2022 Dec; 35(12):e15970. PubMed ID: 36346028
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study.
Mohamed EM; Younes AH; Hussein GM
J Cosmet Laser Ther; 2020 Feb; 22(2):107-110. PubMed ID: 32216566
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
[TBL] [Abstract][Full Text] [Related]
32. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
33. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
Lueangarun S; Namboonlue C; Tempark T
J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
[TBL] [Abstract][Full Text] [Related]
34. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
35. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
Figueiredo Souza L; Trancoso Souza S
Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of low-fluence 1,064 nm Q-Switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
Lee DB; Suh HS; Choi YS
J Cosmet Laser Ther; 2014 Dec; 16(6):264-70. PubMed ID: 24245978
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
[TBL] [Abstract][Full Text] [Related]
39. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
[TBL] [Abstract][Full Text] [Related]
40. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.
Vachiramon V; Sirithanabadeekul P; Sahawatwong S
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
